Chemical Name: Ibrutinib
Molecular Formula: C25H24N6O2
Formula Weight: 440.5
CAS No.: 936563-96-1
Ibrutinib is used to treat chronic lymphocytic leukemia, Waldenstrom's macroglobulinemia, and as a second-line treatment for mantle cell lymphoma, marginal zone lymphoma, and chronic graft vs host disease
Ibrutinib is a kind of Bruton tyrosine kinase (BTK) inhibitor, it could be used for the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). MCL and CLL are belonged to the B-cell non-Hodgkin's lymphoma, which is difficult to cure and easy to recurrent. Common chemical immunotherapy does not have the targeting, often occurs 3 or 4 adverse reactions. Ibrutinib and B lymphocytes could target with BTK which is necessary for formation, differentiation, and transmission of information, inhibit BTK activity irreversibly, and inhibit tumor cell proliferation and survival effectively.
Ibrutinib (Imbruvica) is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia
Looking for ideal Anticancer Active Ingredient
Manufacturer & supplier ? We have a wide selection at great prices to help you get creative. All the Btk Inhibitor 1 R EnantioMer are quality guaranteed. We are China Origin Factory of Ibrutinib N-1 Intermediate Anticancer
. If you have any question, please feel free to contact us.
Product Categories : Anticancer/Antitumor/Antineoplastic